Litcius/Paper detail

Epigenetically silenced PD-L1 confers drug resistance to anti-PD1 therapy in gastric cardia adenocarcinoma

Tianyu Zhu, Zhihao Hu, Zhuoyin Wang, Hengxuan Ding, Ruixin Li, Junfeng Sun, Guojun Wang

2020International Immunopharmacology15 citationsDOI

Topics & Concepts

MethylationDNA methylationPD-L1Cancer researchAdenocarcinomaHypomethylating agentCancerBisulfite sequencingBisulfiteCombination therapyMolecular biologyMedicineBiologyGeneInternal medicineImmunotherapyGene expressionBiochemistryCancer Immunotherapy and BiomarkersEpigenetics and DNA MethylationImmune cells in cancer
Epigenetically silenced PD-L1 confers drug resistance to anti-PD1 therapy in gastric cardia adenocarcinoma | Litcius